Analyst stock forecast
DiaMedica Therapeutics Stock Forecast and Analyst Price Target
DMAC analyst target range, upside, consensus rating and coverage count.
Direct answer
DiaMedica Therapeutics's average price target is $15.50.
The target implies +137.4% from the recorded current price, and the consensus rating is none.
The verified range is $11.00 to $25.00, with 4 analysts in the current consensus when available.
Forecast evidence checked August 4, 2026.
Verified data
- Current price
- $6.53
- Average price target
- $15.50
- High price target
- $25.00
- Low price target
- $11.00
- Target upside
- +137.4%
- Consensus rating
- none
- Analysts
- 4
- Evidence date
- August 4, 2026
- Valid through
- August 11, 2026